Laurus Labs Q4 FY25 PAT up 208% to Rs. 234 Cr
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
The plant will have installed production capacity of 3,120 MT/month
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Raichur site is the group’s largest API facility and part of a wider network of seven sites
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
Subscribe To Our Newsletter & Stay Updated